KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Equity Average (2016 - 2025)

Historic Equity Average for Bristol Myers Squibb (BMY) over the last 16 years, with Q4 2025 value amounting to $18.6 billion.

  • Bristol Myers Squibb's Equity Average rose 1047.4% to $18.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.6 billion, marking a year-over-year increase of 1047.4%. This contributed to the annual value of $17.4 billion for FY2025, which is 4378.46% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Equity Average of $18.6 billion as of Q4 2025, which was up 1047.4% from $18.0 billion recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Equity Average high stood at $41.0 billion for Q1 2021, and its period low was $16.8 billion during Q4 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Equity Average value was $32.1 billion (recorded in 2022), while the average stood at $29.5 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Equity Average plummeted by 5506.38% in 2024 and then soared by 1047.4% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Equity Average (Quarter) stood at $40.8 billion in 2021, then dropped by 4.59% to $38.9 billion in 2022, then fell by 4.05% to $37.4 billion in 2023, then plummeted by 55.06% to $16.8 billion in 2024, then increased by 10.47% to $18.6 billion in 2025.
  • Its Equity Average stands at $18.6 billion for Q4 2025, versus $18.0 billion for Q3 2025 and $17.5 billion for Q2 2025.